Management of anticoagulant therapy during pregnancy in patients with prosthetic heart valves.
D000014:Abnormalities, Drug-Induced; D000328:Adult; D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D001021:Aortic Valve; D001022:Aortic Valve Insufficiency / Q000601:surgery; D005260:Female; D005313:Fetal Death; D006350:Heart Valve Prosthesis; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007743:Labor, Obstetric; D008943:Mitral Valve; D008944:Mitral Valve Insufficiency / Q000601:surgery; D010630:Phenindione / Q000627:therapeutic use; D011183:Postoperative Complications / Q000517:prevention & control; D011247:Pregnancy; D011249:Pregnancy Complications, Cardiovascular; D013923:Thromboembolism / Q000517:prevention & control*; D014859:Warfarin / Q000627:therapeutic use
D000925:Anticoagulants; D010630:Phenindione; D014859:Warfarin; D006493:Heparin